Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
出版年份 2021 全文链接
标题
Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
作者
关键词
-
出版物
Pneumonia
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-12-06
DOI
10.1186/s41479-021-00092-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysis
- (2021) Animut Alebel et al. BMC INFECTIOUS DISEASES
- The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis
- (2021) Marjon E. A. Wormgoor et al. Journal of Translational Medicine
- Umbilical cord mesenchymal stem cells for COVID ‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial
- (2021) Giacomo Lanzoni et al. Stem Cells Translational Medicine
- Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial
- (2021) Masoud Nouri‐Vaskeh et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
- (2021) Charles D. Bengtson et al. Frontiers in Medicine
- COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
- (2021) Rebecca Forman et al. HEALTH POLICY
- Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
- (2021) Dipayan Chaudhuri et al. INTENSIVE CARE MEDICINE
- A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm
- (2021) Mandana Pouladzadeh et al. Internal and Emergency Medicine
- JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
- (2021) Chong-xiang Chen et al. LEUKEMIA
- An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
- (2021) Álvaro Réa-Neto et al. Scientific Reports
- Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
- (2021) Sultan AM Saghir et al. Therapeutics and Clinical Risk Management
- Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
- (2021) Rizaldy Taslim Pinzon et al. Journal of Infection and Public Health
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
- (2020) Fengxiang Song et al. RADIOLOGY
- Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
- (2020) Jesús Villar et al. Lancet Respiratory Medicine
- SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection
- (2020) Francesca Colavita et al. ANNALS OF INTERNAL MEDICINE
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
- (2020) David M.G. Halpin et al. EUROPEAN RESPIRATORY JOURNAL
- A Review of Coronavirus Disease-2019 (COVID-19)
- (2020) Tanu Singhal INDIAN JOURNAL OF PEDIATRICS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of COVID-19 Respiratory Distress
- (2020) John J. Marini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
- (2020) Dan Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
- (2020) Janice Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anti-IL6R role in treatment of COVID-19-related ARDS
- (2020) Franco Maria Buonaguro et al. Journal of Translational Medicine
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient
- (2020) Emily Hillaker et al. PHARMACOTHERAPY
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
- (2020) Jun Kobayashi et al. Annals of Intensive Care
- COVID-19 pathophysiology: A review
- (2020) Koichi Yuki et al. CLINICAL IMMUNOLOGY
- Pathogenesis of COVID-19-induced ARDS: implications for an aging population
- (2020) Manuel A. Torres Acosta et al. EUROPEAN RESPIRATORY JOURNAL
- Emerging pharmacological therapies for ARDS: COVID-19 and beyond
- (2020) Shahd Horie et al. INTENSIVE CARE MEDICINE
- Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis
- (2020) Yong Hu et al. JOURNAL OF CLINICAL VIROLOGY
- Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
- (2020) Saeed K. Alzghari et al. JOURNAL OF CLINICAL VIROLOGY
- Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports
- (2020) Brandon Michael Henry et al. JOURNAL OF CRITICAL CARE
- Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
- (2020) Hunter B. Moore et al. Journal of Trauma and Acute Care Surgery
- Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
- (2020) Andreas Neubauer et al. LEUKEMIA
- Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells
- (2020) Bing Liang et al. MEDICINE
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients
- (2020) Masaomi Nangaku et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
- (2020) Jonathan Rilinger et al. Trials
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
- (2020) Enrico Capochiani et al. Frontiers in Medicine
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome
- (2020) Abolghasem Allahyari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Oxford–AstraZeneca COVID-19 vaccine efficacy
- (2020) Maria Deloria Knoll et al. LANCET
- Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study
- (2020) Olena Bolotova et al. PLoS One
- Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
- (2020) Alejandro Piscoya et al. PLoS One
- Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy
- (2020) Yukihiro Shimizu World Journal of Clinical Cases
- Acute respiratory distress syndrome
- (2019) Michael A. Matthay et al. Nature Reviews Disease Primers
- Insights into the immuno-pathogenesis of acute respiratory distress syndrome
- (2019) Judith Ju Ming Wong et al. Annals of Translational Medicine
- HIV screening in men and women in Senegal: coverage and associated factors; analysis of the 2017 demographic and health survey
- (2019) Ndeye Aïssatou Lakhe et al. BMC INFECTIOUS DISEASES
- Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
- (2018) Cong Liu et al. Frontiers in Immunology
- Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy
- (2017) Kyung-Yil Lee INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Inhibition of CD8+T cells and elimination of myeloid cells by CD4+ Foxp3−T regulatory type 1 cells in acute respiratory distress syndrome
- (2016) Guang-Gang Li et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo
- (2016) Michael C. W. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
- (2012) Yiwu Yan et al. CELL RESEARCH
- Sympathetic ophthalmia: a review of literature
- (2011) Nemaly Chaithanyaa et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis
- (2010) Sachin Sud et al. INTENSIVE CARE MEDICINE
- Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: A need for early immune-modulators for severe cases
- (2010) Kyung-Yil Lee et al. MEDICAL HYPOTHESES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now